Marvell stock pops 11% as Nvidia takes $2 billion stake, continuing run of similar bets

Jonathan Raa | Nurphoto | Getty Images Shares of Marvell Technology surged more than 11% after Nvidia announced plans to invest $2 billion in the semiconductor company as businesses race to meet ballooning artificial intelligence demand. The deal ties Marvell into Nvidia’s AI ecosystem, making it easier for customers to build on the infrastructure. Both…

Read Full News

Why Dubai Princess Sheikha Mahra changed her Instagram name to “Xtianna” after divorce

Of course, you can’t talk about Mahra’s reinvention without mentioning the man currently holding her hand. Her engagement to Moroccan-American rapper French Montana (Karim Kharbouch) in late 2025 surprised everyone. It was a union which was much talked about for long, but was now confirmed now bringing both the music and royal worlds together. On…

Read Full News

‘Pure evil’: Piers Morgan names the most dangerous person he’s ever interviewed in 35-year career |

In his 35-year career, Piers Morgan called Erin Caffey, convicted teen murderer, “nearest to pure evil.” After 35 years spent interviewing world leaders, celebrities and some of the most controversial figures in modern culture, Piers Morgan has singled out one individual who, he says, unsettled him more than anyone else, not a politician or public…

Read Full News

Microsoft hit with UK competition regulator probe over software business

Microsoft has been hit with a fresh probe into its business software ecosystem by the British competition regulator, as Europe steps up its efforts to diversify tech stacks and increase digital sovereignty. The U.K.’s Competition and Markets Authority announced on Tuesday it is launching a “strategic market status (SMS) investigation” into the tech giant’s suite…

Read Full News

Novo Nordisk launches Wegovy subscription for GLP-1 obesity drugs

Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription program for its Wegovy obesity drug products that aims to ensure cash-paying patients see lower, “predictable” monthly prices.  Eligible patients can choose between three-, six- or 12-month subscriptions for the Wegovy injection or the two…

Read Full News